Adjuvant GEMOX for biliary tract cancer: Updated relapse-free survival and first overall survival results of the randomized PRODIGE 12-ACCORD 18 (UNICANCER GI) phase III trialJulien Edeline, Éveline Boucher, Franck Bonnetain et al.|Annals of Oncology|2017Cited by 4
55P Adjuvant gemcitabine-based chemotherapy for biliary tract cancer: Pooled analysis of the BCAT and PRODIGE-12 studiesJulien Edeline, Tomoki Ebata, M. Benabdelghani et al.|Annals of Oncology|2020Cited by 1